Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Corso

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Trends in Molecular Medicine|June 5, 2016
How Can Gastric Cancer Molecular Profiling Guide Future Therapies?Simona Corso, Silvia Giordano
Cancer Discovery|August 1, 2013
Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspectiveSimona Corso, Silvia Giordano
Journal of Experimental & Clinical Cancer Research : CR|November 3, 2022
The importance of being CAFs (in cancer resistance to targeted therapies)Sabrina Rizzolio, Silvia Giordano, Simona Corso
Oncotarget|September 17, 2017
Targeted therapies for gastric cancer: failures and hopes from clinical trialsMaria Apicella, Simona Corso, Silvia Giordano
Cancers|December 18, 2020
Patient-Derived Cancer ModelsMaria Flavia Di Renzo, Simona Corso
Trends in Molecular Medicine|June 14, 2005
Cancer therapy: can the challenge be MET?Simona Corso, Paolo M Comoglio, Silvia Giordano
Cancer Treatment Reviews|October 25, 2025
Precision oncology in gastric cancer: Shaping the future of personalized treatmentCristina Migliore, Elisabetta Fenocchio, Silvia Giordano, et al.
Cancer Treatment Reviews|March 15, 2021
Microsatellite instability in Gastric Cancer: Between lights and shadowsElisabetta Puliga, Simona Corso, Filippo Pietrantonio, et al.
Cancers|August 14, 2020
Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma CellsSabrina Rizzolio, Simona Corso, Silvia Giordano, et al.
Molecular Oncology|July 12, 2014
Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependenceValentina Martin, Simona Corso, Paolo M Comoglio, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Trends in Molecular Medicine|June 5, 2016
How Can Gastric Cancer Molecular Profiling Guide Future Therapies?Simona Corso, Silvia Giordano
Cancer Discovery|August 1, 2013
Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspectiveSimona Corso, Silvia Giordano
Journal of Experimental & Clinical Cancer Research : CR|November 3, 2022
The importance of being CAFs (in cancer resistance to targeted therapies)Sabrina Rizzolio, Silvia Giordano, Simona Corso
Oncotarget|September 17, 2017
Targeted therapies for gastric cancer: failures and hopes from clinical trialsMaria Apicella, Simona Corso, Silvia Giordano
Cancers|December 18, 2020
Patient-Derived Cancer ModelsMaria Flavia Di Renzo, Simona Corso
Trends in Molecular Medicine|June 14, 2005
Cancer therapy: can the challenge be MET?Simona Corso, Paolo M Comoglio, Silvia Giordano
Cancer Treatment Reviews|October 25, 2025
Precision oncology in gastric cancer: Shaping the future of personalized treatmentCristina Migliore, Elisabetta Fenocchio, Silvia Giordano, et al.
Cancer Treatment Reviews|March 15, 2021
Microsatellite instability in Gastric Cancer: Between lights and shadowsElisabetta Puliga, Simona Corso, Filippo Pietrantonio, et al.
Cancers|August 14, 2020
Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma CellsSabrina Rizzolio, Simona Corso, Silvia Giordano, et al.
Molecular Oncology|July 12, 2014
Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependenceValentina Martin, Simona Corso, Paolo M Comoglio, et al.
Pageof 6